Composition
Dapagliflozin Tablets
Interested in this product?
Contact us for export pricing, bulk orders, and regulatory documentation.
Request QuoteProduct Overview
Dapaberg contains Dapagliflozin, an SGLT2 inhibitor that lowers blood glucose by reducing renal glucose reabsorption, with additional cardiovascular and renal benefits.
Indication
Type 2 diabetes mellitus, heart failure with reduced ejection fraction, and chronic kidney disease.
Packaging
10 x 10 Alu-Alu strip pack
Storage
Store below 25°C, protected from light.
Export Ready
Available for export with full regulatory documentation, COA, and dossier support for international registration.
Disclaimer: This product information is intended for healthcare professionals and authorized distributors only. It is not intended as medical advice. Please refer to the full prescribing information for complete details. Regulatory approvals may vary by country.